Introduction {#Sec1}
============

Intradialytic exercise (IDE) is defined as exercise training performed during the hemodialysis (HD) session to increase the patient's strength and endurance, and hence targeting various physiological and psychosocial parameters. The nature of the IDE varies from resistance to aerobic exercise and stretching, with different equipment used corresponding to the type of exercise. IDE has demonstrated a positive effect on the overall health and hospitalization rate of HD patients \[[@CR1], [@CR2]\].

The Kidney Disease Improving Global Outcomes (KDIGO) guidelines recommend a full integration of exercise in the daily life of chronic kidney disease patients (at least 30 min/day, 5 times a week) taking into consideration their cardiovascular health and level of tolerance \[[@CR3]\]. Unfortunately, there are no clear guidelines for IDE, and the IDE experience is described, from the patient's perspective, as "going into the unknown" \[[@CR4]\].

Sedentary lifestyle, low quality of life and reduced VO~2~ max are associated with increased mortality risk among HD patients \[[@CR5]--[@CR7]\]. IDE has shown to have positive effects in HD patients; this was evident from the results of previous systematic reviews where IDE improved the efficiency of dialysis (Kt/V) \[[@CR8], [@CR9]\], VO~2~ max \[[@CR8]--[@CR10]\], and quality of life (QOL) \[[@CR8]--[@CR11]\]. In addition, several studies have also shown positive effects of IDE on solute clearance, notably with regard to serum phosphorus levels (P) \[[@CR1], [@CR12]--[@CR14]\]. Possible explanations of the underlying mechanism are the increased cardiac output and blood flow to lower extremities, and capillary vasodilation, resulting in more solutes being transferred to the vascular compartment and reaching the dialyzer membrane for diffusion \[[@CR15]\]. Thus IDE could be a cornerstone in the management of HD patients.

Capitanini et al. suggested that, to sustain an exercise program for HD patients, there needs to be a healthcare team led by a nephrologist and including a cardiologist, physiotherapist, exercise physiologist, renal dietitian, and a nurse \[[@CR16]\]. To date, some dialysis units are lucky enough to have ergometers that connect to the HD beds or chairs so permitting their HD patients to benefit from this IDE aerobic exercise. Furthermore, exercise prescription for several chronic conditions \[[@CR17]\] is in alignment with the current international physical activity (PA) guidelines which is 150 min/week of moderate intensity aerobic PA \[[@CR18]\]. Even though other recommendations include resistance training, this review will focus on the effects of aerobic IDE since combined training is more complex for HD patients.

This review adds serum phosphate (P) as a new parameter (with respect to existing reviews), since it is an important risk factor associated with negative outcomes in HD patients \[[@CR19]\]. The objective of this review is to explore all published interventions on aerobic IDE, identify the optimal protocols used, and highlight the effects of these trials on patient QOL, P, dialysis efficiency (urea reduction ratio \[URR\], Kt/V), vitamin D3, parathyroid hormone (PTH), and serum C-reactive protein (CRP), intake of P binders, the number of emergency HD sessions, cost effectiveness, mortality and hospitalization rate.

Methods {#Sec2}
=======

Eligibility criteria {#Sec3}
--------------------

All eligible studies were included if they met the predetermined inclusion and exclusion criteria detailed in the PICOS model (Table [1](#Tab1){ref-type="table"}). There was no language restriction, nor filters applied to the search.

Table 1Eligibility criteriaCriteriaInclusion criteriaExclusion criteriaPopulationChronic adult HD patientsAll other patientsInterventionAerobic IDENon aerobic exerciseNon-IDE interventionComparisonPre-post interventionOutcomesIntervention-control groupQOLSerum PKt/vURRVitamin D3PTHCRPMortalityStudy typesHospitalization rateInterventional studiesInterventions \< 1 monthNon-interventional trialsConference abstractsSystematic reviewsMeta-analyses

Search strategy {#Sec4}
---------------

Potential studies were identified using the Pubmed, Medline (Ovid), Embase (Ovid), Cochrane, and Cinahl (EBSCO) databases up to June 12, 2018. In addition, references of included articles were hand-searched by 2 reviewers; pertinent references were retrieved and submittted to full text screening. The search strategy included the following terms selected from the Medical Subject Headings (MeSH): renal replacement therapy, renal dialysis, hemodiafiltration, hemodialysis/home, renal insufficiency, renal osteodystrophy, dialysis, kidneys/artificial, motor activity, exercise, walking, physical exertion, physical endurance, exercise tolerance, physical fitness, exercise therapy, sports, bicycling, psychomotor performance, motor skills; it also included the following keywords: renal, kidney, insufficien\*, replacement\*, failure\*, osteodytroph\*, necrosis, necroses, artificial, dialy\*, microdialy\*, haemodialy\*, hemodialy\*, intradialy\*, hemodiafiltration\*, haemodiafiltration\*, hemo-diafiltration\*, haemo-diafiltration\*, cardio, muscle\*, muscular, endurance, aerobic\*, physical, training, capacity\*, capab\*, therap\*, toleran\*, prescri\*, interven\*, techni\*, physical\*, motion\*, activit\*, fit, fitness, function\*, exert\*, modalit\*, motor, skill\*, psychomotor, performance. The asterisk (\*) sign denotes that the word before it will be searched in all its possible versions. Boolean operators "OR, AND" were used for the search. The full search strategy is available on <https://www.crd.york.ac.uk/PROSPEROFILES/52062_STRATEGY_20180205.pdf>.

This systematic review and meta-analysis followed the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines \[[@CR20]\] and was registered on Prospero (registration ID: CRD42016052062; available at: <http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42016052062>). A medical librarian validated the search strategy.

Study selection {#Sec5}
---------------

Three reviewers (N.S., M.K., C.K.) independently assessed all retrieved articles. Overall average pairwise percent agreement between the 3 reviewers was 96.667% (Fleiss Kappa coefficient = 0.967; Krippendorff's Alpha = 0). Only one article was disagreed upon by reviewer \#3, and a consensus was reached through discussion between the 3 reviewers.

Data analysis {#Sec6}
-------------

Three authors (N.S., M.K., C.K.) developed a template for data extraction; information extracted included patient characteristics, study design, exercise prescription and outcome variables (Kt/v, URR, serum P, QOL, vitamin D3, PTH, CRP, cost effectiveness, hospitalization rate, number of emergency HD, intake of P binders, mortality). Eligible articles were reviewed, and relevant data was then extracted, and organized into 2 main results tables by one author (N.S.).

The meta-analysis was performed using the Explanatory Software for Confidence Intervals (ESCI) program \[[@CR21]\], based on the change in P, QOL-PCS, QOL-MCS and Kt/v which is the difference in mean between the start and end of the intervention. Pooled standard deviation was also calculated using the following formula:$$\documentclass[12pt]{minimal}
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                \begin{document}$$\surd \left[ {\left( {{\text{SEM pre intervention}}} \right)^{{\text{2}}} + {\text{ }}\left( {{\text{SEM post intervention}}} \right)^{{\text{2}}} } \right]$$\end{document}$$ where SEM = SD/√sample size. Heterogeneity was assessed across studies using the diamond ratio (DR); a DR \> 2 implies considerable heterogeneity \[[@CR22]\]. In the case of heterogeneity, a random-effects model was used. The meta-analysis was conducted for outcomes reported in a minimum of 3 studies, due to the potential for greater uncertainty with fewer studies \[[@CR23]\]. The effect size (ES) of controlled studies was calculated, when possible, to evaluate the effectiveness of the IDE intervention. The reported ES was based on the relative size of Cohen's d, which categorizes the studies in the following four levels: d \< 0.2 = negligible effect, over 0.2 = a small effect, over 0.5 = a medium effect, and over 0.8 = a large effect \[[@CR24]\]. The corresponding 95th confidence intervals (CIs) were also reported for each outcome.

Results {#Sec7}
=======

This systematic review was able to identify a wide range of parameters, possibly related to a positive effect of IDE, such as Kt/v, P, QOL, URR, hospitalization, and CRP. After title and abstract screening, the searches resulted in 15,092 articles, of which 52 were eligible for full text screening. The authors excluded 25 articles for one of the following reasons: no intervention was conducted, study outcomes were not measured, the study included children, had mixed types of exercise or non-aerobic exercises, had an intervention duration of \< 1 month, or the full text could not be retrieved even after contacting the authors. Thus 22 articles were included in this review (Fig. [1](#Fig1){ref-type="fig"}). Only the randomized controlled trials (RCTs) and the interventions with comparison groups with common outcomes were included in the meta-analysis (12 studies). The main characteristics of controlled and uncontrolled studies are presented respectively in Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"}. The percentage change of all outcomes reported in Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"} was calculated by the authors using the pre and post outcome results using the following formula: ((Post Outcome Result -- Pre Outcome Result)/Pre Outcome Result)\*100.

Fig. 1Flow chart of study selection based on the PRISMA statement

Table 2Intradialytic aerobic exercise and quality of life studiesReferences and countrySampleInterventionOutcomesDesignExercise prescriptionVariables + Groups% Change (Cohen's d)*p* valueWu et al. \[[@CR25]\]ChinaI (n = 32); C (n = 33)RCT:I: \[QOL-SF36\]+ 37.7%\< 0.05^a,b^Age (yrs ± SD)3 months; 3 times/weekI: 5 min warm up + 10--15 min of cycling Intensity: Borg scale set between 12--16^¶^C: \[QOL-SF36\]+ 2.8%NS^a^I (45/37--48); C: (44/41--50)20 min/sessionC: 10--15 min simple stretching exercisesGender:Setting: 1 HD unitI: 84.4% M; C: 84.8% MDe Lima et al. \[[@CR1]\]BrazilI (n = 10); C (n = 11)RCT:I: cyclingI: \[KDQOL-SF 1.3---physical functioning\]NR\< 0.05^b^Age (yrs ± SD)2 months; 3 times/week Intensity: Borg scale set between 10--12^¶^I: \[KDQOL-SF 1.3---pain\]NR\< 0.05^b^I (43.1 ± 13.3); C (43.5 ± 11.1)20 min/sessionC: Received routine careI: \[KDQOL-SF 1.3---symptoms\]NR\< 0.04^b^Gender:Setting: 1 HD unitI: \[KDQOL-SF 1.3---sleeping\]NR\< 0.006^b^I: 50% M; C: 54.5% MI: \[KDQOL-SF 1.3---sexual function\]NR\< 0.01^b^I: \[KDQOL-SF 1.3---energy/fatigue\]NR\< 0.02^b^C: \[KDQOL-SF 1.3\]NR\< 0.05^b^Giannaki et al. \[[@CR26]\]GreeceI (n = 15); C (n = 7)RCT:I: cyclingI: \[QOL-SF36---MCS\]+ 15.2% (0.26)NS^a^, NS^b^Age (yrs ± SD)6 months; 3 times/week Intensity: 60--65% of patient's maximal exercise capacityC: \[QOL-SF36---MCS\]− 4.5%NS^a^I (56.4 ± 12.5); C (56.8 ± 16.5)45--60 min/sessionC: Received routine care + placebo pillsI: \[QOL-SF36---PCS\]+ 17.7% (0.27)0.003^a^, NS^b^Gender:Setting: 1 HD unitC: \[QOL-SF36---PCS\]+ 9.4%NS^a^I: 73.3% M; C: 71.4% MDobsak et al. \[[@CR27]\]Czech RepublicI (n = 11); C (n = 10)RCT:I: 5 min warm up + 20--40 min cycling + 5 min cool downI: \[QOL-SF36---MCS\]+ 8.5% (0.03)0.001^a^, NR^b^Age (yrs ± SD)4.6 months; 3 times/week Intensity: 30--60% of patient's peak workloadC: \[QOL-SF36---MCS\]+ 1.7%NS^a^I (58.2 ± 7.2); C (60.1 ± 8.1)30--50 min/sessionC: Received routine careI: \[QOL-SF36---PCS\]+ 11.1% (0.19)0.006^a^, NR^b^Gender:Setting: 1 HD unitC: \[QOL-SF36---PCS\]− 1.5%NS^a^I: 36.3% M; C: 66.6% MKoh et al. \[[@CR28]\]AustraliaI (n = 15); C (n = 16)RCT:I: 2 weeks of conditioning: 15 min cycling/sessionI: \[QOL-SF36---MCS\]− 3.3% (0.26)NS^a^, NS^b^Age (yrs ± SD)5 months; 3 times/week 9 weeks: 30 min cycling/sessionC: \[QOL-SF36---MCS\]− 3.0%NS^a^I (52.3 ± 10.9); C (51.3 ± 14.4)15 to 45 min/session 9 weeks: 45 min cycling/sessionI: \[QOL-SF36---PCS\]− 11.3% (0.35)NS^a^, NS^b^Gender:Setting: 3 HD units Intensity: Borg scale set between 12--13^¶^C: \[QOL-SF36---PCS\]No ΔNS^a^I: 66.6% M; C: 50%C: Received routine careSakkas et al. \[[@CR29]\]GreeceI (n = 7); C (n = 7)2 Groups intervention:I: 5 min warm up + 45 min cycling + 5 min cool downI: \[QOL-SF36---MCS\]+ 26.6% (0.99)NS^a^, NR^b^Age (yrs ± SD)3.7 months; 3 times/week Intensity: 65--75% of patient's maximum power capacityC: \[QOL-SF36---MCS\]− 10.1NS^a^I (48 ± 14); C (70 ± 11)55 min/sessionC: Received routine careI: \[QOL-SF36---PCS\]+ 23.8% (1.78)0.01^a^, NR^b^Gender:Setting: 1 HD unitC: \[QOL-SF36---PCS\]+ 14.5%NS^a^I: 71.4% M; C: 71.4% MParsons et al. \[[@CR30]\]CanadaI (n = 6); C (n = 7)RCT:I: three 15 min exercise bouts of cyclingI: \[QOL-SF36---physical function\]+ 1.1%NS^a^, NR^b^Age (yrs ± SD)2 months; 3 times/week Intensity: 40--50% of maximal work capacityC: \[QOL-SF36---physical function\]− 4.2%NS^a^I (60 ± 17); C (49 ± 25)45 min/sessionC: Received routine careI: \[QOL-SF36---role emotional\]− 7.7%NS^a^, NR^b^Gender:Setting: 1 HD unitC: \[QOL-SF36---role emotional\]+ 17.6%NS^a^I: 50% M; C: 57.1% MI: \[QOL-SF36---bodily pain\]+ 2.1%NS^a^, NR^b^C: \[QOL-SF36---bodily pain\]+ 10.1%NS^a^I: \[QOL-SF36---general health\]− 13.7%NS^a^, NR^b^C: \[QOL-SF36---general health\]− 13.4%NS^a^I: \[QOL-SF36---vitality\]− 6.9%NS^a^, NR^b^C: \[QOL-SF36---vitality\]+ 1.2%NS^a^I: \[QOL-SF36---social function\]− 2.6%NS^a^, NR^b^C: \[QOL-SF36---social function\]+ 12.4%NS^a^I: \[QOL-SF36---role physical\]+ 16.4%NS^a^, NR^b^C: \[QOL-SF36---role physical\]+ 26.7%NS^a^I: \[QOL-SF36---mental health\]+ 3.4%NS^a^, NR^b^C: \[QOL-SF36---mental health\]+ 1.0%NS^a^Painter et al. \[[@CR31]\]USAPainter et al. \[[@CR31]\]USA^¥^I (n = 166); C (n = 28)2 Groups intervention:I: strengthening + stretching exercises at home for 2 months followed by intradialytic cycling for 2 monthsI: \[QOL-SF36---MCS\]+ 4.7% (0.0)NR^a^, NS^b^Age (yrs ± SD)2 months; 30 min/sessionC: \[QOL-SF36---MCS\]− 0.1%NR^a^I (55.9 ± 15.15); C (52.8 ± 16.8)Setting: 5 HD units Intensity: based on the perceived exertion scale to fit their tolerable rateI: \[QOL-SF36 -PCS\]+ 9.1% (0.64)NR^a^, 0.001^b^Gender:C: \[QOL-SF36---PCS\]− 15.6%NR^a^I: 42.9% M; C: 34.6% MC: Received routine careChigira et al. \[[@CR32]\]Japann = 7Single group Intervention:15 min of warm up and stretching + 20 min cycling + 1 min cool down\[WHO-QOL26\]+ 4.1%NSAge (yrs ± SD)3 months; 2--3 times/week 40 min/sessionIntensity: Borg scale set between 11 and 13^¶^Gender: 71.4% MSetting: 1 HD unitBae et al. \[[@CR33]\]Korean = 10Single group Intervention:5 min warm up + 30 min cycling + 2 min cool downI: \[QOL-SF36\]+ 14.7%NSAge (yrs ± SD)3 months; 2--3 times/weekIntensity: at 35 rpm + Borg scale set between 11 and 13^¶^56.5 ± 4.430 min/sessionGender: 40% MSetting: 1 HD unitMusavian et al. \[[@CR14]\]Irann = 16Single group Intervention:(a) 8 weeks: control period(d) \[QOL-SF36\]+ 20.8%0.007Age (yrs ± SD)4 non-consecutive months(b) 8 weeks: 30 min of passive cycling51.9 ± 1.573 times/week(c) 8 weeks: washoutGender: 81.2% M30 min/session(d) 8 weeks: 30 min of active cyclingSetting: 1 HD unitIntensity: not reportedBohm et al. \[[@CR34]\]Canadan = 20Single group Intervention:Cycling intensity: Borg scale set between 12 and 14^¶^\[QOL-SF36- PCS\]+ 11.4%\*NSAge (yrs ± SD)6 months; 3 times/week\[QOL-SF36- MCS\]− 2.0%\*NS52 ± 14.560 min/sessionGender: 73% MSetting: 4 HD unitsGolebiowski et al. \[[@CR35]\]Polandn = 21Single group Intervention:Cycling intensity: physical load was individually adapted to exercise tolerance\[QOL- SF36v2\]IncreaseNSAge (yrs ± SD)3 months; 3 times/weekSub group analysis of patients with the64.2 ± 13.150 ± 19 min/sessionlowest \[physical function\] initially: \[physical functioning\]+ 88.8%0.04Gender: 51.7% MSetting: 1 HD unitBesnier et al. \[[@CR42]\]Francen = 6Single group InterventionCycling at a speed of 60--70 turns per minute"\[QOL-SF36---PCS\]+ 12.3%NRAge (yrs ± SD)3 months; 3 times/weekIntensity: Moderate intensity exercise was maintained when patient reaches the value of his first ventilator threshold\[QOL-SF36---MCS\]− 2.8%NR72.5 ± 7.830 min/sessionSignificance unreportedGender: 66.6% MSetting: 1 HD unitReboredo et al. \[[@CR13]\]Braziln = 14Single group InterventionPre intervention conditioning: 12 weeks of stretching for 10 min of the lower limbs\[QOL-SF36---physical function\]+ 17.1%\< 0.05Age (yrs ± SD)3 month; 3 times/wee\[QOL-SF36---social functioning\]+ 15.1%\< 0.0547.6 ± 12.830 min/sessionIntervention: 15 min of stretching and warm up + 30 min of cycling + 15 min cool down and stretching\[QOL-SF36---mental health\]+ 18.1%\< 0.05Gender: 28.6% MSetting: 1 HD unit\[QOL-SF36---role physical\]+ 13.4%NSIntensity: Borg scale set between 11--13^¶^\[QOL-SF36---pain\]+ 22.2%NS\[QOL-SF36---general health\]− 6.4%NS\[QOL-SF36---vitality\]+ 4.1%NS\[QOL-SF36---role emotional\]+ 18.0%NSMcMurray et al. \[[@CR36]\]Australian = 19Single group Intervention:Cycling Intensity: based on individual's capacity to cope with the program\[QOL-SF12---MCS\]− 12.6%NSAge (yrs ± SD)3 months; 3 times/week\[QOL-SF12---PCS\]− 22.2%NS67.6 ± 11.240 min/sessionGender: 63.6% MSetting: 1 HD unitParsons et al. \[[@CR37]\]Canadan = 13Single group Intervention:Cycling: two 30 min exercise bouts with a 30 min recovery period between bouts\[KDQOL\]NRNSAge (yrs ± SD)5 months; 3 times/week\[QOL-SF36\]NRNS53.0 ± 18.060 min/sessionIntensity: based on patient's capacityGender: 61.5% MSetting: 2 HD unitsOrder of the studies: randomized controlled studies followed by single group studies, and in descending order of the publication year*p* significance, *Yrs* years, *SD* standard deviation, *M* male, *RCT* randomized controlled trial, *Min* minutes, *HD* hemodialysis, *I* intervention, *C* control, *QOL* quality of life, *NS* non-significant, *NR* not reported, *PCS* physical component summary, *MCS* mental component summary, *USA* United States of America^¶^Borg scale set between 12--14 is described a "somewhat hard" and is equivalent to a moderate intensity exercise; ^a^significance for within group comparison with baseline; ^b^significance of intervention compared with control group; ¥ this study was a subgroup study so we only reported the results of the mother study; \*measurement reported from a figure

Table 3Intradialytic aerobic exercise and biochemical/other parameters studiesReferences and countrySampleInterventionOutcomesDesignExercise prescriptionVariables + Groups% Change (Cohen's d)*p* value***Dialysis efficiency***Groussard et al. \[[@CR38]\]I (n = 8); C (n = 10)RCT:I: cyclingI: \[Kt/v\]+ 8.3% (0.95)NR^a,b^FranceAge (yrs ± SD)3 months; 3 times/weekIntensity: 55--60% of the peak power outputC:\[Kt/v\]− 10.2%NR^a,b^I (66.5 ± 4.6); C (68.4 ± 3.7)40 min/sessionC: Received routine careGender:Setting: 2 HD unitsI: 62.5% M; C: 77.7% MDobsak et al. \[[@CR27]\]I (n = 11); C (n = 10)RCT:I: 5 min warm up + 20--40 min cycling + 5 min cool downI: \[Kt/v\]+ 14.6% (1.01)0.02^a^, NR^b^Czech RepublicAge (yrs ± SD)4.6 months; 3 times/weekIntensity: 30--60% of patient's peak workloadC:\[Kt/v\]− 5.6%NS^a^, NR^b^I (58.2 ± 7.2); C (60.1 ± 8.1)30--50 min/sessionC: Received routine careI : \[URR %\]+ 10.9% (1.44)0.001^a^, NR^b^Gender:Setting: 1 HD unitC: \[URR %\]− 3.3%NS^a^I: 36.3% M; C: 66.6% MAfshar et al. \[[@CR39]\]I (n = 7); C (n = 7)RCT:I: 5 min warm up + 10--30 min cyclingI: \[Kt/v\]No **(**0.34)NS^a^, NR^b^IranAge (yrs ± SD)2 months; 3 times/weekIntensity: Borg scale set between 12--16^¶^C: \[Kt/v\]+ 0.9%NS^a^I (50.7 ± 21.06); C (53 ± 19.4)10--30 min/sessionC: Received routine careGender:100% MSetting: 1 HD unitSakkas et al. \[[@CR29]\]I (n = 7); C (n = 7)2 Groups intervention:I: 5 min warm up + 45 min cycling + 5 min cool downI: \[Kt/v\]+ 8.3% (0.22)NS^a^, NR^b^GreeceAge (yrs ± SD)3.7 months; 3 times/weekIntensity: 65--75% of patient's maximum power capacityC:\[Kt/v\]+ 30%0.05I (48 ± 14); C (70 ± 11)55 min/sessionC: Received routine careGender:Setting: 1 HD unitI: 71.4% M; C: 71.4% MParsons et al. \[[@CR30]\]I (n = 6); C (n = 7)RCT:I: three 15 min exercise bouts of cyclingI: \[Kt/v\]+ 0.7% (0.18)NS^a^, NR^b^CanadaAge (yrs ± SD)2 months; 3 times/weekIntensity: 40--50% of maximal work capacityC: \[Kt/v\]− 3.1%NS^a^, NR^b^I (60 ± 17); C (49 ± 25)45 min/sessionC: Received routine careGender:Setting: 1 HD unitI: 50% M; C: 57.1% MChigira et al. \[[@CR32]\]n = 7Single group Intervention15 min of warm up and stretching + 20 min cycling + 1 min cool down\[Kt/v\]+ 6.6%NSJapanAge (yrs ± SD)3 months; 2--3 times/week70.6 ± 4.440 min/sessionIntensity: Borg scale set between 11 and 13^¶^Gender: 71.4% MSetting: 1 HD unitMusavian et al. \[[@CR14]\]n = 16Single group Intervention:(a) 8 weeks: control period(b) \[Kt/v\]+ 8.3%NSIranAge (yrs ± SD)2 non-consecutive months(b) 8 weeks: 30 min of passive cycling(d) \[Kt/v\]− 4.3%NS51.9 ± 1.53 times/week(c) 8 weeks: washout(b) \[URR %\]+ 1.9%NSGender: 81.2% M30 min/session(d) 8 weeks: 30 min of active cycling(d) \[URR %\]− 3.3%NSSetting: 1 HD unitIntensity: not reportedParker et al. \[[@CR2]\]n = 102Single group InterventionHD units had established intradialytic bicycling program as part of their routine care\[URR %\]+ 1.4%0.02CanadaAge (yrs ± SD)6 months; 3 times/week65.6 ± 13.5≥ 30 min/sessionIntensity: Borg scale set between 12--13^¶^Gender: 67.6% MSetting: 2 HD unitsReboredo et al. \[[@CR13]\]n = 14Single group Intervention:Pre intervention conditioning: 12 weeks of stretching for 10 min of the lower limbs\[Kt/V\]+ 41.6%\< 0.05BrazilAge (yrs ± SD)3 months; 3 times/week47.6 ± 12.830 min/sessionIntervention: 15 min of stretching and warm up + 30 min of cycling + 15 min cool down and stretchingGender: 28.6% MSetting: 1 HD unitIntensity: Borg scale set between 11--13^¶^Parsons et al. \[[@CR37]\]n = 13Single group Intervention:Cycling: two 30 min exercise bouts with a 30 min recovery period between bouts\[Kt/v\]+ 15.4%\< 0.05CanadaAge (yrs ± SD)5 months; 3 times/week\[URR %\]+ 7.1%\< 0.0553.0 ± 18.060 min/sessionIntensity: based on patient's capacityGender: 61.5% MSetting: 2 HD units***Phosphorus***De Lima et al. \[[@CR1]\]I (n = 10); C (n = 11)RCT:I: cyclingI: \[P mg/dl\]− 3.5% (0.14)NS^a^BrazilAge (yrs ± SD)2 months; 3 times/weekIntensity: Borg scale set between 10--12^¶^C: \[P mg/dl\]+ 3.7%NS^a^I (43.1 ± 13.3); C (43.5 ± 11.1)20 min/sessionC: Received routine careGender:Setting: 1 HD unitI: 50% M; C: 54.5% MMakhlough et al. \[[@CR12]\]I (n = 25); C (n = 23)RCT:I: Aerobic movement exercise of range capacityI: \[P mg/dl\]− 24.0% (0.56)0.003^a^IranAge (yrs ± SD)2 months; 3 times/weekIntensity: based on patient's capacityC: \[P mg/dl\]+ 0.5%NS^a^, NR^b^I (53.3 ± 14.27); C (56.16 ± 10.77)15 min/ sessionC: Received routine careGender:Setting: 1 HD unitI: 73.9% M; C: 54.2% MWilund et al. \[[@CR40]\]I (n = 8); C (n = 9)RCT:I: cyclingI: \[P mg/dl\]+ 25% (0.9)NS^a^, NR^b^USAAge (yrs ± SD)4 months; 3 times/weekIntensity: Borg scale set between 12--14^¶^C: \[P mg/dl\]− 6.3%NS^a^, NR^b^I (60.8 ± 3.2); C (59.0 ± 4.9)45 min/sessionGender:Setting: 1 HD unitC: Received routine careI: 37.5% M; C: 42.8% MMusavian et al. \[[@CR14]\]n = 16Single-group Intervention:(a) 8 weeks: control period(b) \[P mg/dl\]− 0.4%NSIranAge (yrs ± SD)2 non-consecutive months(b) 8 weeks: 30 min of passive cycling(d) \[P mg/dl\]− 13.1%0.00451.9 ± 1.573 times/week(c) 8 weeks: washoutGender: 81.2% M30 min/session(d) 8 weeks: 30 min of active cyclingSetting: 1 HD unitIntensity: not reportedReboredo et al. \[[@CR13]\]n = 14Single-group InterventionPre intervention conditioning: 12 weeks of stretching for 10 min\[P mg/dl\]− 7.0%NSBrazilAge (yrs ± SD)3 monthsof the lower limbs47.6 ± 12.83 times/weekIntervention: 15 min of stretching and warm up + 30 min of cycling + 15 min cool down and stretchingGender: 28.6% M30 min/sessionSetting: 1 HD unitIntensity: Borg scale set between 11--13^¶^McMurray et al. \[[@CR36]\]n = 19Single-group Intervention:Cycling\[P mmol/l\]− 2.7%NSAustraliaAge (yrs ± SD)3 months; 3 times/weekIntensity: based on individual's capacity to cope with the program67.6 ± 11.240 min/sessionGender: 63.6% MSetting: 1 HD unit***Others***Afshar et al. \[[@CR39]\]I (n = 7); C (n = 7)RCT:I: 5 min warm up + 10--30 min cyclingI: \[hs-CRP mg/l\]− 83.8%Sig^a^, 0.005^b^IranAge (yrs ± SD)2 months; 3 times/weekIntensity: Borg scale set between 12--16^¶^C: \[hs-CRP mg/l\]+ 1.4%NS^a^I (50.7 ± 21.06); C (53 ± 19.4)10--30 min/sessionC: Received routine careGender: 100% MSetting: 1 HD unitWilund et al. \[[@CR40]\]I (n = 8); C (n = 9)RCT:I: cyclingI: CRP (mg/dl)− 5.7%NS^a^, NR^b^USAAge (yrs ± SD)4 months; 3 times/weekIntensity: Borg scale set between 12--14^¶^C: CRP (mg/dl)− 3.2%NS^a^, NR^b^I (60.8 ± 3.2); C (59.0 ± 4.9)45 min/sessionGender:Setting: 1 HD unitC: Received routine careI: 37.5% M; C: 42.8% MGolebiowski et al. \[[@CR35]\]n = 21Single-group Intervention:Cycling\[CRP mg/l\]+ 15.0%NSPolandAge (yrs ± SD)3 months; 3 times/weekIntensity: physical load was individually adapted to exercise tolerance64.2 ± 13.150 ± 19 min/sessionGender: 51.7% MSetting: 1 HD unitParker et al. \[[@CR2]\]n = 102Single-group InterventionHD units had established intradialytic bicycling program as part of their routine care\[Hospitalization rate\]− 2.6%NSCanadaAge (yrs ± SD)(Retrospective Study)65.6 ± 13.56 months; 3 times/weekIntensity: Borg scale set between 12--13^¶^Gender: 67.6% M≥ 30 min/sessionSetting: 2 HD unitsOrder of the studies: randomized controlled studies followed by single group studies, and in descending order of the publication year*p* significance, *Yrs* years, *SD* standard deviation, *M* male, *RCT* randomized controlled trial, *Min* minutes, *HD* hemodialysis, *I* intervention, *C* control, *Sig* significant, *NS* non-significant, *NR* not reported, *P* phosphorus, *URR* urea reduction ration, *PRU* percentage reduction ration, *CRP* C-reactive protein^a^significance for within group comparison with baseline; ^b^significance of intervention compared with control group; ^¶^Borg scale set between 12--14 is described a "somewhat hard" and is equivalent to a moderate intensity exercise

General specifications of studies {#Sec8}
---------------------------------

The number of participants in a single study ranged from 6 to 194, and the mean age of participants varied between 43.3 and 72.5 years. Male gender was predominant in most studies except for 5 \[[@CR13], [@CR27], [@CR31], [@CR33], [@CR40], [@CR41]\]. The IDE in 13 studies consisted of cycling only \[[@CR1], [@CR2], [@CR14], [@CR26], [@CR28], [@CR30], [@CR34], [@CR36]--[@CR40], [@CR42]\], and 8 studies included warm-up and stretching in addition to cycling \[[@CR13], [@CR25], [@CR27], [@CR29], [@CR31]--[@CR33], [@CR35]\]. One study consisted of aerobic range of motion capacity only \[[@CR12]\]. Exercise intensity was assessed in 11 studies \[[@CR1], [@CR2], [@CR13], [@CR25], [@CR28], [@CR31]--[@CR34], [@CR39], [@CR40]\] using the Borg Rating of Perceived Exertion Scale, set between 10 and 16. The other studies used either the patient's maximal exercise capacity, ranging between 30 and 75% of oxygen consumption capacity (VO~2~ max) \[[@CR26], [@CR27], [@CR29], [@CR37], [@CR38]\] or the patient's individual capacity (4 studies) \[[@CR12], [@CR35]--[@CR37]\]. One study did not report the intensity \[[@CR14]\] and another one set the cycle speed at 60--70 revs/min \[[@CR39]\]. Single IDE sessions varied in duration between 15 and 60 min, a duration of ≥ 30 min being the most used one. As for the length of the interventions, it varied between 2 and 6 months. IDE was performed at every HD session (2 or 3 times per week).

IDE effects on quality of life {#Sec9}
------------------------------

A total of 17 studies \[[@CR1], [@CR13], [@CR14], [@CR25]--[@CR37], [@CR42]\] showed the effect of aerobic IDE on QOL. Data were very heterogeneous due to the use of different QOL instruments. Accordingly, a meta-analysis including all studies could not be conducted. Table [2](#Tab2){ref-type="table"} shows detailed data from each study.

A total of 5 studies were included in the meta-analysis \[[@CR26]--[@CR29], [@CR31]\] and reported the QOL---physical component scale (PCS) (Table [4](#Tab4){ref-type="table"}) and the QOL---mental component scale (MCS) (Table [4](#Tab4){ref-type="table"}), in a total number of 282 patients (214 patients in the experimental group and 68 patients in the control group). Results showed considerable heterogeneity. Overall, our meta-analysis indicated that aerobic IDE had a significant positive effect on both the QOL-PCS and QOL-MCS. In our meta-analysis, the study with large effect size for the QOL-PCS and the QOL-MCS had the youngest patients in the intervention group and the oldest in the control group \[[@CR29]\]. The study with medium effect size for the QOL-PCS was that of Painter et al. in which the methodology used was radically different compared to the other studies, i.e. there were 2 months of conditioning exercises at home prior to the 2 months of IDE \[[@CR31]\]. Moreover, the positive effect of IDE preconditioning on the QOL was also seen in the single arm interventional study conducted by Musavian et al. \[[@CR14]\].

Table 4Forest plot of a random effect meta-analysis assessing the change in QOL-PCS, QOL-MSC, Kt/v and P in IDE interventions versus controls

As for the total QOL score, the most significant percentage change was reported in an RCT by Wu et al. (37.7%) where the design included 5 min warm-up, and 20 min cycling exercise for a period of 3 months at an intensity of 12--16 points on the Borg scale \[[@CR25]\].

Also, two single-group interventions \[[@CR14], [@CR33]\] had a high percentage change in the total QOL-SF-36 score: 20.8% \[[@CR14]\] and 14.7% \[[@CR33]\]. These latter two studies had a similar IDE program to Wu et al. \[[@CR25]\] except that they had a longer duration exercise session.

IDE effects on phosphorus {#Sec10}
-------------------------

Six studies \[[@CR1], [@CR12]--[@CR14], [@CR36], [@CR40]\] assessed the effect of IDE on serum phosphorus (P) level. Only 3 were eligible to be included in the meta-analysis. They showed considerable heterogeneity, and indicated that IDE had no significant effect on serum P levels (Table [4](#Tab4){ref-type="table"}). Makhlough et al. reported the highest positive effect size and was the only to show a significant P decrease \[[@CR12]\]; their intervention consisted of aerobic range of motion capacity for 15 min/session for 2 months. This study was also unique in the fact of having the highest mean baseline serum P (7.68 mg/dl) for the IDE group compared to the other studies included in this systematic review. Contrary to the other 2 RCTs \[[@CR1], [@CR12]\], Wilund et al. showed an increase in the P level post IDE; the study had the most prolonged intervention period (4 months) and exercise duration (45 min), yet the lowest sample size; the mean starting value for serum P in the intervention group was 5.2 mg/dl \[[@CR40]\].

As for the other 3 single-group interventions \[[@CR13], [@CR14], [@CR36]\], serum P levels were lower at the end of the study, the decrease being statistically significant only in the shortest duration intervention \[[@CR14]\], where patients exercised for 30 min/session (but the intensity was not reported). It is worth noting that the 3 studies all started with a P level ranging between 4.82 and 5.7 mg/dl.

IDE effects on dialysis efficiency {#Sec11}
----------------------------------

Ten studies assessed the effect of IDE on Kt/V \[[@CR13], [@CR14], [@CR27], [@CR29], [@CR30], [@CR32], [@CR37]--[@CR39]\] and URR \[[@CR2], [@CR14], [@CR27], [@CR37]\]. Only 5 were eligible for the meta-analysis \[[@CR27], [@CR29]--[@CR31], [@CR38]\], and they showed considerable heterogeneity. Their pooled analysis showed that IDE had no significant effect on Kt/V (Table [4](#Tab4){ref-type="table"}). Nevertheless, Dobsak et al. was able to show a large effect size and a positive change (+ 14.6%) on Kt/V \[[@CR27]\]. This study was unique in its gender distribution (63.7% of the intervention group were females), duration (4.6 months), intensity (30--60%), and session length (30--50 min). Another study conducted by Groussard et al. had a large effect size with a positive change (+ 8.3%) on Kt/v \[[@CR38]\]. Two other studies also reported a positive change in Kt/v post intervention but had a small effect size \[[@CR29], [@CR30]\].

Among the single-group interventions, the 2 studies that showed the most significant change in Kt/v were those by Reboredo et al. and Parsons et al. \[[@CR13], [@CR37]\]; the former study included 3 months IDE preconditioning before the intervention and the latter one had the longest IDE duration per session and intervention length. Concerning URR, one RCT showed a large effect size and reported a positive change (+ 10.9%) in URR post intervention \[[@CR27]\]; the single-group intervention study of Parsons et al. also showed a positive URR change and had the longest session length (60 min) \[[@CR37]\].

Effect of IDE on inflammatory status variables {#Sec12}
----------------------------------------------

Three studies assessed the effect of IDE on CRP \[[@CR35], [@CR39], [@CR40]\]. Only 2 were RCTs \[[@CR39], [@CR40]\] and showed a decrease in CRP level contrary to the single-group pilot study \[[@CR35]\] where CRP increased but not significantly. Afshar et al.'s study showed the most significant change and was unique in its gender distribution, being 100% male \[[@CR39]\]. A meta-analysis was not possible due to the low number of eligible studies reporting on CRP.

Effect of IDE on hospitalizations {#Sec13}
---------------------------------

Hospitalization rate was reported in only 1 single-group intervention \[[@CR2]\], and showed a non-significant decrease over 6 months.

Effect of IDE on other outcomes {#Sec14}
-------------------------------

None of the articles identified through our screening methodology measured vitamin D3, PTH, cost effectiveness, number of emergency HD, intake of P binders, and mortality, which were initially planned to be assessed in this systematic review. Thus, we cannot report on these parameters.

Discussion {#Sec15}
==========

This systematic review focused on the effect of aerobic IDE programs in an HD setting. The conclusions drawn from this review are not only based on the meta-analysis results, since some of our main outcome parameters were trialed only in studies without comparators.

A meta-analysis of 5 articles showed that aerobic IDE improves both QOL-PCS and QOL-MCS. This is partly in line with findings reported in the literature, where the meta-analysis of studies on aerobic and resistance IDE programs showed that IDE had a significant difference on the QOL-PCS but not on the QOL-MCS \[[@CR8], [@CR10]\]. Pre-IDE muscle conditioning and young age were identified as the key components of success in terms of patients being able to maintain a long-term IDE program and thus harvest the positive clinical outcomes \[[@CR14], [@CR31]\]. However, a recent review conducted by Gomes et al. showed that aerobic IDE was not associated with improvement in the QOL \[[@CR43]\]. However, Gomes et al.'s meta-analysis included an article in which IDE targeted malnourished patients; thus it has different selection criteria and its findings cannot be generalized to the general HD population. Our review, however, included 1 article with a large sample size that might have affected the results. In addition, our meta-analysis was based on the outcome change rather than on post intervention values.

In our review we could not identify an overall effect of IDE on P levels in HD patients. However, a possible effective IDE recipe to improve serum P was identified by Makhlough et al. \[[@CR12]\] where patients included in the study were hyperphosphatemic (serum P \> 4.5 mg/dl) \[[@CR44]\] and the exercise involved was a 2-month aerobic exercise program involving range of motion capacity. Moreover, Musavian et al. had an added value of preconditioning exercises before implementation of IDE programs on their serum P results \[[@CR14]\]. These results may be explained by the fact that hyperphosphatemic patients are the ones that need additional therapies to improve their current status, thus they would be the ones that reap the effect of IDE the most \[[@CR14], [@CR44]\]. Out of the 3 RCTs focusing on serum P, two of them had an increase in P in their control groups, thus we postulate that the IDE program reversed the natural deterioration of serum P commonly seen among HD patients; this gives more importance to the positive clinical effect of IDE. HD patients have numerous comorbidities reducing the magnitude of improvement \[[@CR31]\]; this very fact may be more obvious when the parameter taken into account is initially in the normal range. Wilund et al. had the highest exercise duration and length of intervention, but the P level increased at the end of the intervention \[[@CR40]\]. The authors did not define the mechanisms of this increase and mentioned their small sample size as a limitation, preventing control for various factors. In addition, Wilund et al. did not report if dietary P was monitored.

Our review did not find an overall positive effect of IDE on Kt/v in HD patients. On the other hand, time seems to be the key for Kt/V improvement with IDE. When comparing the 5 RCTs, characterized by similar duration of exercise per dialysis session and intensity, the most prolonged exercise program \[[@CR27]\] resulted in the most significant change. Also, gender may play a role since the only intervention that showed no change was in a study on male patients only. Among the single-group interventions, Reboredo et al. showed the largest positive significant change (+ 41.6%) in Kt/V \[[@CR13]\]; this study had the youngest patients, and the highest female gender percentage among the other comparable studies \[[@CR14], [@CR32], [@CR37]\]. It included conditioning before intervention and stretching along with cycling. Another meta-analysis \[[@CR8]\] showed that IDE groups had higher Kt/v values than the control group; however, the type of exercise included also resistance and stretching \[[@CR31], [@CR45], [@CR46]\], not only aerobic exercise. Unlike Sheng et al., we were not able to identify a clear effect of aerobic IDE on Kt/V. Thus we cannot exclude that other exercise modalities could be more beneficial.

There was no association between IDE and mortality risk or rates of hospitalization in the included studies; this was also reported in a previous systematic review \[[@CR11]\] where no RCT on exercise training with chronic kidney disease patients reported exercise as a direct cause of death. Nephrologists should capitalize on this fact to advocate exercise to their patients. Nevertheless, data insufficiency in this field may be a major source of hesitation in advocating IDE.

Other factors beyond those studied in the present paper may provide arguments in favor of IDE. After the initiation of HD therapy, patients' lean tissue mass tends to decrease and fat tissue mass and body mass index (BMI) tend to increase \[[@CR47]\], which may contribute to sarcopenic obesity \[[@CR48]\]. Fluctuation of fat and lean tissue is affected by gender, comorbidities and the initial body composition \[[@CR47]\]. Thus, assessing the body composition in HD patients is crucial, especially since BMI is not always a good indicator in this population \[[@CR49]\]. Mortality is higher in HD patients with a low fat tissue index (FTI) and lean tissue index (LTI) \[[@CR49]\]; whereas survival is higher in patients with fat and lean tissue compartments lying between the 10th and 90th percentile of a healthy population \[[@CR49]\]. It has also been shown that physical inactivity is, in combination with a decline in lean tissue, related to muscle weakness \[[@CR50]\] which is an important determinant of outcome in dialysis patients \[[@CR51]\]. Whereas resistance-based IDE was shown to increase muscle strength and quadriceps cross-sectional area, its effect on LTI was less apparent, this in contrast to treatment with anabolic steroids \[[@CR52]\]. Therefore, assessing body composition as well as muscle strength on a routine basis may be useful for both risk stratification as well as targeted interventions.

Cardiovascular diseases are a major comorbidity in HD patients \[[@CR53]\]. National and international guidelines for cardiac rehabilitation include education, exercise training and psychological support \[[@CR54]\] as part of their programs. HD patients are mostly cardiac patients; therefore, like the cardiologist, nephrologists should be encouraged to focus on their patient's behavioral goals through counseling and follow-ups.

HD patients spend an average of 12 h weekly being sedentary on dialysis; thus it is a good opportunity to integrate IDE. IDE might not be a miraculous cure, but it could surely add more functionality to the time spent in HD, improve patients' QOL, decrease anxiety, and maybe increase adherence to the treatment. Perhaps, IDE could be coupled with music, since music therapy in HD patients has shown it can reduce anxiety \[[@CR55]\], pain and nausea \[[@CR56]\], while it improves blood pressure, quality of sleep, fever, cramps, anxiety and depression levels, pain, and itching \[[@CR57]\].

Based on the studies that showed statistically significant positive effects of IDE on all study parameters in our review, a putative recipe for aerobic exercise in chronic hemodialysis patients could be suggested (Table [5](#Tab5){ref-type="table"}). Exercise, specifically intradialytic, should be part of the HD treatment protocol. Guidelines are required for IDE to be an adjunct therapy to HD.

Table 5Putative recipe for aerobic IDEPreconditioningStrengthening and stretching exercise 2 months prior to exercise initiationModalityWarm up: Range capacity exercise + CyclingFrequency3 times per weekIntensityBorg scale average rating of 12 pointsOr 60--65% of the peak power outputDurationRange capacity exercises: 15 min + Cycling: 30--45 min

Limitations {#Sec16}
-----------

The limitations of this review were the lack of quality analysis of the studies. As for the general limitations related to the available published literature, these ranged from the selection of the healthier HD patients, to the scarcity of the available interventions, to the limited number of eligible interventions for meta-analysis, to the diversity in exercise intensity, duration and modality across the studies. Furthermore, the presence of a publication bias in this new researched field cannot be underestimated. The authors could not report on all the primary and secondary outcomes that they had planned to evaluate because some of these were unavailable in the selected studies.

Conclusions {#Sec17}
===========

In conclusion, the results of this systematic review suggest that aerobic IDE did not impose any health hazard in HD patients and its incorporation into clinical practice can result in significant improvement in QOL-PCS and QOL-MCS \[[@CR26]--[@CR29], [@CR31]\]. Since sarcopenic obesity is a prevalent phenomenon among HD patients, this can be a call for making IDE a routine practice in HD units. But the accurate mode of delivery (intensity, type, methods) needs to be tailored to each subgroup of patients within the context of the country, culture, and healthcare system.

Future research should assess the long-term effectiveness and safety of IDE. Most of the studies were conducted in Western countries and thus more insights are needed concerning other regions, such as the Middle East. Last but not least, the mortality rate related to IDE should be investigated in order to strengthen the rationale for IDE programs.
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